Urology Devices Market by Product ((Dialysis, Endoscopes, Lasers, Lithotripsy, Robotic System), (Guidewires, Catheters, Stents)), Application(Kidney Diseases, Urological Cancer, BPH), End User(Hospital, Dialysis Center, Homecare) - Global Forecast to 2026
[198 Pages Report] The global urology devices market is projected to reach USD 46.4 billion by 2026 from USD 38.0 billion in 2021, at a CAGR of 4.1%. Market growth is driven by the rising incidence and prevalence of urological conditions and the growing number of hospitals and investments in endoscopy and laparoscopy facilities.
To know about the assumptions considered for the study, Request for Free Sample Report
COVID-19 Impact on Global Urology Devices Market
COVID-19 is an infectious disease caused by the novel coronavirus. Largely unknown before the outbreak began in Wuhan (China) in December 2019, COVID-19 grew from a regional crisis to a global pandemic in just a matter of a few weeks. With the World Health Organization (WHO) officially declaring the outbreak of COVID-19 a pandemic, a mix of established pharmaceutical and biopharmaceutical companies, as well as small startups, have stepped forward to develop treatments and vaccines that target the infection caused by the novel coronavirus. The COVID-19 pandemic has caused disruption in health systems worldwide. This has had a profound impact on urological care and urology care providers. The growing number of COVID-19 cases across the globe has inundated many healthcare facilities with critically ill patients. The COVID-19 strain commonly causes acute respiratory distress in patients and may result in acute kidney injury and, in some cases, kidney failure. According to the American Society of Nephrology, approximately 10−50% of patients with severe COVID-19 admitted to intensive care units have kidney failure that requires some form of dialysis. The growing cases of COVID-19-infected patients across the globe is anticipated to boost the demand for dialysis procedures. As a result, the demand for home dialysis machines has increased owing to the increasing preference for home dialysis treatment due to travel restrictions.
Market Dynamics
Driver: Growing preference for minimally invasive procedures
Over the years, minimally invasive surgeries (MIS) have undergone a drastic transformation in terms of technological advancements, which has brought about a paradigm shift in the way urological procedures are performed in operating rooms. The advantages offered by minimally invasive surgical devices include fewer scars, quicker recovery periods, shorter hospital stays, reduced blood loss and trauma, lower risk of infection, and reduced overall healthcare costs. In the urology field, MIS involves robotics, endoscopy, and laparoscopy to access the urinary tract and associated organs for diagnosis, treatment, and management of urological conditions. The most commonly used robotic systems by urologists is the da Vinci robotic surgery system by Intuitive Surgical (US). This system utilizes a surgical console in which a surgeon controls instruments attached to mechanized arms.
Opportunity: Emerging markets offer lucrative opportunities
Emerging economies such as China, India, South Korea, Brazil, and Mexico offer significant growth opportunities to major market players. This can be attributed to their low regulatory barriers, improvements in healthcare infrastructure, growing patient population, and rising healthcare expenditure. The regulatory policies in the Asia Pacific are more adaptive and business-friendly than those in developed countries. This, along with the increasing competition in mature markets, has drawn key players in the urology devices market to focus on emerging countries. For instance, in April 2018, B. Braun opened five new medical production facilities in Penang, Malaysia, and in 2017, it established a subsidiary in Zambia.
Restraint: High degree of consolidation
The top players—Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International Inc. (US), Olympus Corporation (Japan), Boston Scientific Corporation (US), Becton, Dickinson and Company (US), and Stryker Corporation (US)—in the urology devices market accounted for a combined majority market share in 2019. There is a high degree of competition among the market players. Only major companies can afford high-capital investments as well as the high cost of R&D and manufacturing. This will prevent new entrants from entering this market. Furthermore, the top players in this market are large and well-established and enjoy a high degree of brand loyalty. New entrants in this market have to compete with existing players and set themselves apart by developing innovative product offerings. The high degree of consolidation acts as a major entry barrier for new entrants, which in turn is expected to restrict investments and thus slow down the growth potential of this market. The requirement of high-capital investments and the high cost of R&D and manufacturing will also deter new players.
“In 2020, instruments segment accounted for the largest share of the urology devices market, by product”
Based on products, the urology devices market is segmented into instruments and consumables & accessories. The instruments segment accounted for the largest share of the urology devices market in 2020. Technological advancements coupled with the launch of new and advanced urology instruments and the increasing incidence of kidney diseases are the major factors driving the growth of this segment.
“In 2020, kidney diseases segment accounted for the largest share in the market, by application”
The urology devices market is segmented into kidney diseases, urological cancer and BPH, pelvic organ prolapse, and other applications based on application. In 2020, the kidney diseases segment accounted for the largest share. The growing patient pool of CKD due to the rising geriatric population is driving the growth of this segment.
“North America is the largest regional market for urology devices”
The global urology devices market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North America accounted for the largest share of the global urology devices market. The North American urology devices market's growth can be attributed to the the increasing prevalence of chronic and lifestyle conditions, increasing healthcare spending, highly developed healthcare system in the US and Canada, and presence of a better reimbursement structure.
To know about the assumptions considered for the study, download the pdf brochure
Some key players in the urology devices market (2021- 2026)
- Fresenius Medical Care AG & Co. KGaA
- Baxter International Inc.
- Olympus Corporation
- Boston Scientific Corporation
- Becton, Dickinson and Company
Scope of the Report
|
Report Metric |
Details |
|
Market size available for years |
2019–2026 |
|
Base year considered |
2020 |
|
Forecast period |
2021–2026 |
|
Forecast units |
Value (USD) |
|
Segments covered |
Product, application, end user, and region |
|
Geographies covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
|
Companies covered |
Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International Inc. (US), Boston Scientific Corporation (US), Becton, Dickinson and Company (US), Olympus Corporation (Japan), B. Braun Melsungen AG (Germany), Stryker Corporation (US), KARL STORZ (Germany), Cook Medical (US), Intuitive Surgical (US), Medtronic plc (Ireland), Cardinal Health (US), Teleflex Incorporated (US), Richard Wolf GmbH (Germany), CompactCath (US), Dornier MedTech (Germany), Nikkiso Co., Ltd. (Japan), Balton Sp. z o.o. (Poland), Dialife SA (Switzerland), Maxer Endoscopy GmbH (Germany), Vimex Sp. z o.o. (Poland), Amsino International, Inc. (US), ROCAMED (Monaco), Well Lead Medical Co., Ltd. (China), Medispec (US), Medical Technologies of Georgia (Georgia), EndoMed Systems GmbH (Germany), Hunter Urology (England), J and M Urinary Catheters LLC (US), and Ribbel International Limited (India). |
This report categorizes the urology devices market into the following segments and subsegments:
By Product
- Instruments
- Dialysis Devices
- Hemodialysis Devices
- Peritoneal Dialysis Devices
- Endoscopes
- Laparoscopes
- Ureteroscopes
- Nephroscopes
- Resectoscopes
- Cystoscopes
- Laser & Lithotripsy Devices
- Endovision & Imaging Devices
- Robotic Systems
- Insufflators
- Endoscopy Fluid Management Systems
- Urodynamic Systems
- Consumables & Accessories
- Dialysis Consumables
- Catheters
- Guidewires
- Retrieval Devices & Extractors
- Surgical Dissectors, Forceps, & Needle Holders
- Dilator Sets & Urethral Access Sheaths
- Stents
- Biopsy Devices
- Tubes & Distal Attachments
- Drainage Bags
- Other Consumables & Accessories
By Application
- Kidney Diseases
- Urological Cancer & BPH
- Pelvic Organ Prolapse
- Other Applications
By End User
- Hospitals, ASCs, & Clinics
- Dialysis Centers
- Home Care Settings
By Region
- North America
- US
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
Recent Developments
- In November 2020, Baxter International Inc. (US) received 510(k) approval from the FDA for its Homechoice Claria automated peritoneal dialysis system with the Sharesource connectivity platform.
- In May 2019, Fresenius Medical Care AG & Co. KGaA (Germany) announced the establishment of a new distribution center in Knoxville, Tennessee. This expansion will support the delivery of products needed for in-center hemodialysis treatment.
- In February 2019, Fresenius Medical Care AG & Co. KGaA (Germany) acquired NxStage Medical, Inc. (US) to widen its product portfolio in the areas of renal and critical care.
Frequently Asked Questions (FAQ):
What are the recent trends affecting the urology devices market?
Recent trends affecting the urology devices market are the COVID-19 outbreak, rising incidence and prevalence of urological conditions, and the growing preference for minimally invasive procedures
What are the different types of urology devices used?
The urology devices market is segmented into instruments and consumables & accessories based on product. In 2020, the instruments segment accounted for the largest share. This can be attributed to the launch of new and advanced urology instruments by key players and the rising preference for minimally invasive surgeries.
Who are the key players in the urology devices market?
The key players in this market are: Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International Inc. (US), Boston Scientific Corporation (US), Becton, Dickinson and Company (US), Olympus Corporation (Japan), B. Braun Melsungen AG (Germany), Stryker Corporation (US), KARL STORZ (Germany), Cook Medical (US), Intuitive Surgical (US), Medtronic plc (Ireland), Cardinal Health (US), Teleflex Incorporated (US), Richard Wolf GmbH (Germany), CompactCath (US), Dornier MedTech (Germany), Nikkiso Co., Ltd. (Japan), Balton Sp. z o.o. (Poland), Dialife SA (Switzerland), Maxer Endoscopy GmbH (Germany), Vimex Sp. z o.o. (Poland), Amsino International, Inc. (US), ROCAMED (Monaco), Well Lead Medical Co., Ltd. (China), Medispec (US), Medical Technologies of Georgia (Georgia), EndoMed Systems GmbH (Germany), Hunter Urology (England), J and M Urinary Catheters LLC (US), and Ribbel International Limited (India).
Who are the key end-users of the urology devices market?
Based on end users, the urology devices market is segmented into hospitals, ASCs, and clinics; dialysis centers; and home care settings. In 2020, the hospitals, ASCs, and clinics segment accounted for the largest share of the urology devices market, mainly due to the increasing adoption of urology instruments as well as consumables to serve the large patient population.
Which region is lucrative for the urology devices market?
Like China, Japan, and India, the emerging economies in the Asia Pacific region will be the lucrative markets for urology devices. .
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 23)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.2.2 MARKETS COVERED
FIGURE 1 UROLOGY DEVICES MARKET SEGMENTATION
1.2.3 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
1.4 LIMITATIONS
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 28)
2.1 RESEARCH DATA
2.2 RESEARCH APPROACH
FIGURE 2 UROLOGY DEVICES MARKET: RESEARCH DESIGN
2.2.1 SECONDARY DATA
2.2.1.1 Key data from secondary sources
2.2.2 PRIMARY DATA
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.3 MARKET SIZE ESTIMATION
2.3.1 BOTTOM-UP APPROACH
FIGURE 4 UROLOGY DEVICES MARKET: BOTTOM-UP APPROACH
2.3.2 TOP-DOWN APPROACH
FIGURE 5 UROLOGY DEVICES MARKET: TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 6 DATA TRIANGULATION METHODOLOGY
2.5 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY (Page No. - 36)
FIGURE 7 UROLOGY DEVICES MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
FIGURE 8 UROLOGY DEVICES MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
FIGURE 9 UROLOGY DEVICES MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
FIGURE 10 UROLOGY DEVICES MARKET, BY REGION, 2021 VS. 2026 (USD MILLION)
4 PREMIUM INSIGHTS (Page No. - 39)
4.1 UROLOGY DEVICES MARKET OVERVIEW
FIGURE 11 RISING PREVALENCE OF UROLOGICAL CONDITIONS TO DRIVE MARKET GROWTH
4.2 UROLOGY INSTRUMENTS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 12 DIALYSIS DEVICES SEGMENT WILL CONTINUE TO DOMINATE THE MARKET IN 2026
4.3 UROLOGY ENDOSCOPES MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 13 LAPAROSCOPES SEGMENT DOMINATES THE MARKET IN 2021
4.4 UROLOGY DEVICES MARKET SHARE, BY END USER, 2021 VS. 2026
FIGURE 14 HOSPITALS, ASCS, & CLINICS ARE THE LARGEST END USERS OF UROLOGY DEVICES
4.5 UROLOGY DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 15 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH RATE IN THE UROLOGY DEVICES MARKET DURING THE FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 43)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 16 UROLOGY DEVICES MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
5.2.1 DRIVERS
5.2.1.1 Rising incidence and prevalence of urological conditions
TABLE 1 GLOBAL PREVALENCE OF URINARY INCONTINENCE
TABLE 2 GLOBAL UROLOGIC CANCER INCIDENCE
TABLE 3 GLOBAL INCIDENCE & PREVALENCE OF PROSTATE CANCER
5.2.1.2 Growing preference for minimally invasive procedures
5.2.1.3 Growing number of hospitals and investments in endoscopy and laparoscopy facilities
5.2.2 RESTRAINTS
5.2.2.1 High degree of consolidation
5.2.2.2 High cost of urology devices
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging markets offer lucrative opportunities
5.3 IMPACT OF COVID-19 ON THE UROLOGY DEVICES MARKET
5.4 PRICING ANALYSIS
TABLE 4 PRICES OF UROLOGY DEVICES (2020)
5.5 PATENT ANALYSIS
5.6 VALUE CHAIN ANALYSIS
FIGURE 17 MAJOR VALUE IS ADDED DURING THE MANUFACTURING & ASSEMBLY PHASE
5.7 SUPPLY CHAIN ANALYSIS
FIGURE 18 DISTRIBUTION—A STRATEGY PREFERRED BY PROMINENT COMPANIES
5.8 ECOSYSTEM ANALYSIS OF THE UROLOGY DEVICES MARKET
FIGURE 19 ECOSYSTEM ANALYSIS OF THE UROLOGY DEVICES MARKET
5.9 PORTER’S FIVE FORCES ANALYSIS
FIGURE 20 HIGH CAPITAL INVESTMENTS TO RESTRICT THE ENTRY OF NEW PLAYERS
5.9.1 THREAT OF NEW ENTRANTS
5.9.2 THREAT OF SUBSTITUTES
5.9.3 BARGAINING POWER OF BUYERS
5.9.4 BARGAINING POWER OF SUPPLIERS
5.9.5 INTENSITY OF COMPETITIVE RIVALRY
5.10 PESTLE ANALYSIS
5.11 REGULATORY LANDSCAPE
5.11.1 NORTH AMERICA
5.11.1.1 US
5.11.1.2 Canada
5.11.2 EUROPE
5.11.3 ASIA PACIFIC
5.11.3.1 China
5.11.3.2 Japan
5.11.3.3 India
5.11.3.4 South Korea
5.11.4 LATIN AMERICA
5.11.4.1 Brazil
5.11.4.2 Mexico
5.11.5 MIDDLE EAST
5.11.6 AFRICA
5.12 TRADE ANALYSIS
5.12.1 TRADE ANALYSIS FOR DIALYSIS INSTRUMENTS
5.12.1.1 Import data for dialysis instruments, by country, 2016—2020 (USD Million)
5.12.2 TRADE ANALYSIS FOR ENDOSCOPES
5.12.2.1 Import data for endoscopes, by country, 2016—2020 (USD Million)
6 UROLOGY DEVICES MARKET, BY PRODUCT (Page No. - 59)
6.1 INTRODUCTION
TABLE 5 UROLOGY DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
6.2 INSTRUMENTS
TABLE 6 UROLOGY INSTRUMENTS MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 7 UROLOGY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
6.2.1 DIALYSIS DEVICES
TABLE 8 DIALYSIS DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 9 DIALYSIS DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
6.2.1.1 Hemodialysis devices
6.2.1.1.1 HHD has gained significance due to improved clinical outcomes for patients
TABLE 10 HEMODIALYSIS DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.1.2 Peritoneal dialysis devices
6.2.1.2.1 Technological advancements in PD devices and increasing product approvals to propel market growth
TABLE 11 PERITONEAL DIALYSIS DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.2 ENDOSCOPES
TABLE 12 ENDOSCOPES MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 13 ENDOSCOPES MARKET, BY TYPE, 2019–2026 (USD MILLION)
6.2.2.1 Laparoscopes
6.2.2.1.1 Growing number of laparoscopy procedures to support the market growth
TABLE 14 LAPAROSCOPES MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.2.2 Ureteroscopes
6.2.2.2.1 Continuous technological advancements to support the growth of this market
TABLE 15 URETEROSCOPES MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.2.3 Nephroscopes
6.2.2.3.1 High cost of maintenance to restrain the market growth
TABLE 16 NEPHROSCOPES MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.2.4 Resectoscopes
6.2.2.4.1 High prevalence of prostate, kidney, and bladder cancers to drive the demand for resectoscopes
TABLE 17 RESECTOSCOPES MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.2.5 Cystoscopes
6.2.2.5.1 Increasing prevalence and incidence of urological cancers to drive the uptake to cystoscopes for early diagnosis and treatment
TABLE 18 CYSTOSCOPES MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.3 LASER & LITHOTRIPSY DEVICES
6.2.3.1 Increasing prevalence of kidney diseases to support market growth
TABLE 19 LASER & LITHOTRIPSY DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.4 ENDOVISION & IMAGING SYSTEMS
6.2.4.1 Need for high-resolution images for better observation of body cavities and organs to propel the market in the coming years
TABLE 20 ENDOVISION & IMAGING SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.5 ROBOTIC SYSTEMS
6.2.5.1 Growing industry-academia collaborations to support market growth
TABLE 21 ROBOTIC SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.6 INSUFFLATORS
6.2.6.1 Increasing volume of laparoscopic procedures to boost the demand for insufflators
TABLE 22 INSUFFLATORS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.7 ENDOSCOPY FLUID MANAGEMENT SYSTEMS
6.2.7.1 Growing incidence of chronic diseases to drive the market growth
TABLE 23 ENDOSCOPY FLUID MANAGEMENT SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.8 URODYNAMIC SYSTEMS
6.2.8.1 Growing patient pool to support the growth of this product segment
TABLE 24 URODYNAMIC SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.3 CONSUMABLES & ACCESSORIES
TABLE 25 UROLOGY CONSUMABLES & ACCESSORIES MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 26 UROLOGY CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
6.3.1 DIALYSIS CONSUMABLES
6.3.1.1 Growing number of dialysis procedures to support market growth
TABLE 27 DIALYSIS CONSUMABLES MARKET, BY REGION, 2019–2026 (USD MILLION)
6.3.2 CATHETERS
6.3.2.1 High prevalence of urinary incontinence will drive the market for catheters
TABLE 28 CATHETERS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.3.3 GUIDEWIRES
6.3.3.1 Development of next-generation hybrid guidewires has created significant growth opportunities
TABLE 29 GUIDEWIRES MARKET, BY REGION, 2019–2026 (USD MILLION)
6.3.4 RETRIEVAL DEVICES & EXTRACTORS
6.3.4.1 Technological advancements to support market growth
TABLE 30 UROLOGY DEVICES MARKET FOR RETRIEVAL DEVICES & EXTRACTORS, BY REGION, 2019–2026 (USD MILLION)
6.3.5 SURGICAL DISSECTORS, FORCEPS, & NEEDLE HOLDERS
6.3.5.1 Growing number of urology procedures to support market growth
TABLE 31 SURGICAL DISSECTORS, FORCEPS, & NEEDLE HOLDERS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.3.6 DILATOR SETS & URETHRAL ACCESS SHEATHS
6.3.6.1 Growing demand for effective endoscopic management of ureteral and renal calculi to support market growth
TABLE 32 DILATOR SETS & URETHRAL ACCESS SHEATHS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.3.7 STENTS
6.3.7.1 Growing prevalence of urological and kidney-related disorders to propel market growth
TABLE 33 STENTS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.3.8 BIOPSY DEVICES
6.3.8.1 High incidence of prostate cancer to drive the uptake of biopsy devices
TABLE 34 BIOPSY DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
6.3.9 TUBES & DISTAL ATTACHMENTS
6.3.9.1 Growing demand for endoscopy is expected to propel the growth of this segment
TABLE 35 TUBES & DISTAL ATTACHMENTS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.3.10 DRAINAGE BAGS
6.3.10.1 Risk of urinary tract infections and skin irritation to restrain the market growth
TABLE 36 DRAINAGE BAGS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.3.11 OTHER CONSUMABLES & ACCESSORIES
TABLE 37 OTHER CONSUMABLES & ACCESSORIES MARKET, BY REGION, 2019–2026 (USD MILLION)
7 UROLOGY DEVICES MARKET, BY APPLICATION (Page No. - 89)
7.1 INTRODUCTION
TABLE 38 UROLOGY DEVICES MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
7.2 KIDNEY DISEASES
7.2.1 GROWING PREVALENCE OF DIABETES AND HYPERTENSION TO SUPPORT MARKET GROWTH
TABLE 39 UROLOGY DEVICES MARKET FOR KIDNEY DISEASES, BY REGION, 2019–2026 (USD MILLION)
7.3 UROLOGICAL CANCER & BPH
7.3.1 RISING PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES TO DRIVE THE MARKET GROWTH
TABLE 40 UROLOGY DEVICES MARKET FOR UROLOGICAL CANCER & BPH, BY REGION, 2019–2026 (USD MILLION)
7.4 PELVIC ORGAN PROLAPSE
7.4.1 HIGH COSTS INVOLVED IN SURGERIES & HIGH REOCCURRENCE RATES TO RESTRAIN THE MARKET GROWTH
TABLE 41 UROLOGY DEVICES MARKET FOR PELVIC ORGAN PROLAPSE, BY REGION, 2019–2026 (USD MILLION)
7.5 OTHER APPLICATIONS
TABLE 42 UROLOGY DEVICES MARKET FOR OTHER APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)
8 UROLOGY DEVICES MARKET, BY END USER (Page No. - 95)
8.1 INTRODUCTION
TABLE 43 UROLOGY DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION)
8.2 HOSPITALS, ASCS, & CLINICS
8.2.1 HOSPITALS, ASCS, & CLINICS ARE THE LARGEST END USERS OF UROLOGY DEVICES
TABLE 44 UROLOGY DEVICES MARKET FOR HOSPITALS, ASCS, & CLINICS, BY REGION, 2019–2026 (USD MILLION)
8.3 DIALYSIS CENTERS
8.3.1 CHANGING REIMBURSEMENT POLICIES IN DEVELOPED COUNTRIES TO RESTRAIN THE MARKET GROWTH
TABLE 45 NUMBER OF DIALYSIS CENTERS IN THE US, BY COMPANY, 2019
TABLE 46 NUMBER OF DIALYSIS CENTERS IN CHINA, 2018
TABLE 47 UROLOGY DEVICES MARKET FOR DIALYSIS CENTERS, BY REGION, 2019–2026 (USD MILLION)
8.4 HOME CARE SETTINGS
8.4.1 IMPROVED PATIENT OUTCOMES AND SHORTER HOSPITAL STAYS TO SUPPORT MARKET GROWTH
TABLE 48 UROLOGY DEVICES MARKET FOR HOME CARE SETTINGS, BY REGION, 2019–2026 (USD MILLION)
9 UROLOGY DEVICES MARKET, BY REGION (Page No. - 101)
9.1 INTRODUCTION
TABLE 49 UROLOGY DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 21 NORTH AMERICA: UROLOGY DEVICES MARKET SNAPSHOT
TABLE 50 NORTH AMERICA: UROLOGY DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 51 NORTH AMERICA: UROLOGY DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 52 NORTH AMERICA: UROLOGY DEVICES MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 53 NORTH AMERICA: UROLOGY DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION)
9.2.1 US
9.2.1.1 The US dominates the North American urology devices market
TABLE 54 US: UROLOGY DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 55 US: UROLOGY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 56 US: UROLOGY DEVICES MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 57 US: UROLOGY DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Rising prevalence of target diseases to drive market growth in Canada
TABLE 58 CANADA: UROLOGY DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 59 CANADA: UROLOGY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 60 CANADA: UROLOGY DEVICES MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 61 CANADA: UROLOGY DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3 EUROPE
TABLE 62 EUROPE: UROLOGY DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 63 EUROPE: UROLOGY DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 64 EUROPE: UROLOGY DEVICES MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 65 EUROPE: UROLOGY DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Germany to dominate the European urology devices market during the forecast period
TABLE 66 GERMANY: UROLOGY DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 67 GERMANY: UROLOGY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 68 GERMANY: UROLOGY DEVICES MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 69 GERMANY: UROLOGY DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.2 UK
9.3.2.1 Rising incidence of kidney conditions to drive market growth in the UK
TABLE 70 UK: UROLOGY DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 71 UK: UROLOGY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 72 UK: UROLOGY DEVICES MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 73 UK: UROLOGY DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 Favorable government initiatives are supporting the market growth in France
TABLE 74 FRANCE: UROLOGY DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 75 FRANCE: UROLOGY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 76 FRANCE: UROLOGY DEVICES MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 77 FRANCE: UROLOGY DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.4 ITALY
9.3.4.1 Favorable medical and healthcare reimbursements are driving the market growth in Italy
TABLE 78 ITALY: UROLOGY DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 79 ITALY: UROLOGY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 80 ITALY: UROLOGY DEVICES MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 81 ITALY: UROLOGY DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 Rising prevalence of CKD in Spain to drive market growth
TABLE 82 SPAIN: UROLOGY DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 83 SPAIN: UROLOGY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 84 SPAIN: UROLOGY DEVICES MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 85 SPAIN: UROLOGY DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.6 REST OF EUROPE
TABLE 86 ROE: NUMBER OF CANCER CASES, BY COUNTRY, 2018
TABLE 87 ROE: UROLOGY DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 88 ROE: UROLOGY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 89 ROE: UROLOGY DEVICES MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 90 ROE: UROLOGY DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 22 ASIA PACIFIC: UROLOGY DEVICES MARKET SNAPSHOT
TABLE 91 APAC: UROLOGY DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 92 APAC: UROLOGY DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 93 APAC: UROLOGY DEVICES MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 94 APAC: UROLOGY DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.1 CHINA
9.4.1.1 China accounts for the largest share of the APAC market
TABLE 95 CHINA: UROLOGY DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 96 CHINA: UROLOGY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 97 CHINA: UROLOGY DEVICES MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 98 CHINA: UROLOGY DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.2 JAPAN
9.4.2.1 Favorable regulatory framework in Japan to support the market growth
TABLE 99 JAPAN: UROLOGY DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 100 JAPAN: UROLOGY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 101 JAPAN: UROLOGY DEVICES MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 102 JAPAN: UROLOGY DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.3 INDIA
9.4.3.1 Healthcare infrastructure improvements and implementation of favorable government initiatives to support market growth in India
TABLE 103 INDIA: UROLOGY DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 104 INDIA: UROLOGY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 105 INDIA: UROLOGY DEVICES MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 106 INDIA: UROLOGY DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.4 REST OF ASIA PACIFIC
TABLE 107 ROAPAC: UROLOGY DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 108 ROAPAC: UROLOGY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 109 ROAPAC: UROLOGY DEVICES MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 110 ROAPAC: UROLOGY DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION)
9.5 LATIN AMERICA
9.5.1 HIGH PREVALENCE OF CHRONIC CONDITIONS TO DRIVE MARKET GROWTH
TABLE 111 LATIN AMERICA: UROLOGY DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 112 LATIN AMERICA: UROLOGY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 113 LATIN AMERICA: UROLOGY DEVICES MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 114 LATIN AMERICA: UROLOGY DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
9.6.1 INCREASING HEALTHCARE EXPENDITURE TO DRIVE THE MARKET GROWTH
TABLE 115 MIDDLE EAST & AFRICA: UROLOGY DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 116 MIDDLE EAST & AFRICA: UROLOGY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 117 MIDDLE EAST & AFRICA: UROLOGY DEVICES MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 118 MIDDLE EAST & AFRICA: UROLOGY DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION)
10 COMPETITIVE LANDSCAPE (Page No. - 138)
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES
10.3 MARKET SHARE ANALYSIS
FIGURE 23 UROLOGY DEVICES MARKET SHARE, BY KEY PLAYER (2019)
10.4 COMPANY EVALUATION QUADRANT
10.4.1 LIST OF EVALUATED VENDORS
10.4.2 STARS
10.4.3 EMERGING LEADERS
10.4.4 PERVASIVE PLAYERS
10.4.5 PARTICIPANTS
FIGURE 24 UROLOGY DEVICES MARKET: COMPETITIVE LEADERSHIP MAPPING, 2019
10.5 COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS (2019)
10.5.1 PROGRESSIVE COMPANIES
10.5.2 STARTING BLOCKS
10.5.3 RESPONSIVE COMPANIES
10.5.4 DYNAMIC COMPANIES
FIGURE 25 UROLOGY DEVICES MARKET: COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS/SMES, 2019
10.6 COMPETITIVE SCENARIO
10.6.1 MARKET EVALUATION FRAMEWORK, 2018-2020
10.6.2 PRODUCT LAUNCHES & APPROVALS
TABLE 119 KEY PRODUCT LAUNCHES & APPROVALS
10.6.3 EXPANSIONS
TABLE 120 KEY EXPANSIONS
10.6.4 ACQUISITIONS
TABLE 121 KEY ACQUISITIONS
10.6.5 PARTNERSHIPS, COLLABORATIONS, & JOINT VENTURES
TABLE 122 KEY PARTNERSHIPS, COLLABORATIONS, & JOINT VENTURES
11 COMPANY PROFILES (Page No. - 148)
11.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, MnM View)*
11.1.1 FRESENIUS MEDICAL CARE AG & CO. KGAA
FIGURE 26 FRESENIUS MEDICAL CARE AG & CO. KGAA: COMPANY SNAPSHOT (2019)
11.1.2 BAXTER INTERNATIONAL, INC.
FIGURE 27 BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT (2019)
11.1.3 BOSTON SCIENTIFIC CORPORATION
FIGURE 28 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2019)
11.1.4 BECTON, DICKINSON AND COMPANY
FIGURE 29 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2020)
11.1.5 OLYMPUS CORPORATION
FIGURE 30 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2020)
11.1.6 B. BRAUN MELSUNGEN AG
FIGURE 31 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2019)
11.1.7 STRYKER CORPORATION
FIGURE 32 STRYKER CORPORATION: COMPANY SNAPSHOT (2019)
11.1.8 INTUITIVE SURGICAL
FIGURE 33 INTUITIVE SURGICAL: COMPANY SNAPSHOT (2019)
11.1.9 MEDTRONIC PLC
FIGURE 34 MEDTRONIC PLC: COMPANY SNAPSHOT (2020)
11.1.10 CARDINAL HEALTH
FIGURE 35 CARDINAL HEALTH: COMPANY SNAPSHOT (2020)
11.2 OTHER PLAYERS
11.2.1 TELEFLEX INCORPORATED
FIGURE 36 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2019)
11.2.2 KARL STORZ
11.2.3 COOK MEDICAL
11.2.4 RICHARD WOLF GMBH
11.2.5 COMPACTCATH
11.2.6 DORNIER MEDTECH
11.2.7 NIKKISO CO., LTD.
11.2.8 DIALIFE SA
11.2.9 MAXER ENDOSCOPY GMBH
11.2.10 WELL LEAD MEDICAL CO., LTD.
11.2.11 ROCAMED
11.2.12 ENDOMED SYSTEMS GMBH
11.2.13 AMSINO INTERNATIONAL, INC.
11.2.14 MEDISPEC
11.2.15 MEDICAL TECHNOLOGIES OF GEORGIA
11.2.16 VIMEX SP. Z O. O.
11.2.17 BALTON SP. Z O.O.
11.2.18 HUNTER UROLOGY
11.2.19 RIBBEL INTERNATIONAL LIMITED
11.2.20 J & M URINARY CATHETERS, LLC
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
12 APPENDIX (Page No. - 191)
12.1 INSIGHTS FROM INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 AVAILABLE CUSTOMIZATIONS
12.5 RELATED REPORTS
12.6 AUTHOR DETAILS
This study involved four major activities in estimating the current size of the urology devices market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate segments and subsegments' market size.
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the urology devices market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry have been identified through extensive secondary research
- The revenues generated by leading players operating in the urology devices market have been determined through primary and secondary research
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources
To know about the assumptions considered for the study, Request for Free Sample Report
Data Triangulation
After arriving at the overall market size applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Report Objectives
- To define, describe, segment, and forecast the global urology devices market by product, application, end user, and region
- To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
- To analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the market segments with respect to five regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
- To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies2
- To track and analyze company developments such as product launches, partnerships, expansions, and acquisitions in the urology devices market
- To benchmark players within the market using the proprietary "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product strategy
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:
Country Information
Urology devices market size and growth rate estimates for countries in the Rest of Europe, the Rest of Asia Pacific, Latin America, and Middle East & Africa
Company profiles
Additional five company profiles of players operating in the urology devices market
Get in-depth analysis of the COVID-19 impact on the Urology Devices Market
Benchmarking the rapid strategy shifts of the Top 100 companies in the Urology Devices Market
Request For Special Pricing
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Urology Devices Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Growth opportunities and latent adjacency in Urology Devices Market